| Patents for C07C 311 - Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups (17,647) |
|---|
| 07/16/2009 | CA2702992A1 Methods of inhibiting bacterial virulence and compounds relating thereto |
| 07/15/2009 | CN101484419A Compositions containing silanes |
| 07/15/2009 | CN101480183A Selective herbicides based on substituted arylsulfonylaminocarbonyl triazolinones and safeners |
| 07/14/2009 | US7560589 Cycloalkylidene compounds as modulators of estrogen receptor |
| 07/14/2009 | US7560473 Amine derivative with potassium channel regulatory function, its preparation and use |
| 07/14/2009 | US7560459 Substituted sulfamate anticonvulsant derivatives |
| 07/14/2009 | CA2464648C Process for resolution of tamsulosin |
| 07/09/2009 | WO2009085177A1 Phenyl acetic acid derivatives as inflammation modulators |
| 07/09/2009 | WO2008147797A3 Ion channel modulators and methods of use |
| 07/09/2009 | US20090176973 Thrombopoietin mimetics |
| 07/09/2009 | US20090176746 4'-{N'-[1-(3,4-dimethylphenyl)-3-methyl-5-oxo-1,5-dihydropyrazol-4-ylidene]hydrazino}-3'-hydroxybiphenyl-4-carboxylic acid; Promotes thrombopoiesis and megakaryocytopoiesis |
| 07/09/2009 | CA2707789A1 Phenyl acetic acid derivatives as inflammation modulators |
| 07/08/2009 | EP2076489A1 Arylsulfonamidyl tetralin derivatives and uses thereof |
| 07/08/2009 | CN101479238A Amine derivative having npyy5 receptor antagonist activity |
| 07/08/2009 | CN101475515A Method for preparing 5-amino-2-chloro-N-(2,4-xylyl)-benzene sulfonic amide in water phase |
| 07/08/2009 | CN101475514A Process for synthesizing ryzalin by trichloromethyl carbonate method |
| 07/08/2009 | CN100509774C Acylsulfonamides as inhibitors of steroid sulfatase |
| 07/08/2009 | CN100509773C Alpha -amino-n-hydroxy-acetamide derivatives |
| 07/07/2009 | US7557140 e.g. 3-[3-(2,4-Difluoro-phenylsulfamoyl)-phenyl]-N-hydroxy-acrylamide; histone deacetylase inhibitor; anticarcinogenic, antiinflammatory agent, autoimmune diseases; leukemia, atheriosclerosis, Alzheimer's disease, rheumatoid arthritis, psoriasis |
| 07/07/2009 | CA2438324C Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical |
| 07/07/2009 | CA2405518C Compounds, compositions and methods for preventing neurodegeneration in acute and chronic injuries in the central nervous system |
| 07/02/2009 | WO2009082347A1 Bis- (sulf onylamino) derivatives for use in therapy |
| 07/02/2009 | WO2009081956A1 Method for producing conjugated aromatic compound |
| 07/02/2009 | WO2009080722A2 Carboxylic derivatives for use in the treatment of cancer |
| 07/02/2009 | WO2009080637A1 Compounds which potentiate the ampa receptor and uses thereof in medicine |
| 07/02/2009 | CA2709510A1 Bis-(sulfonylamino) derivatives for use in therapy |
| 07/02/2009 | CA2708450A1 Method for producing conjugated aromatic compound |
| 07/01/2009 | EP2074083A1 New sulfonamide derivatives as bradykinin antagonists |
| 07/01/2009 | CN101472883A Arylsulfonamidyl tetralin derivatives and uses thereof |
| 07/01/2009 | CN100507549C Acoustic sensors and methods |
| 07/01/2009 | CN100507548C Acousto-mechanical detection systems and methods of use |
| 06/30/2009 | US7553971 Aryl aniline β2 adrenergic receptor agonists |
| 06/30/2009 | US7553831 Beta-secretase inhibitors; inhibiting cleavage of amyloid precursor protein (APP); hydroxy-functional disubstituted amines such as 6-(([[(2S,3S)-4-(3,5-difluorophenyl)-3-((3-[(dipropylamino)carbonyl]benzoyl)amino)-2-hydroxybutyl](ethyl)amino]carbonyl)amino)hexanoic acid |
| 06/25/2009 | WO2009079375A1 Histone deacetylase inhibitors |
| 06/25/2009 | WO2009040517A3 Methods of synthesis of certain hydroxamic acid compounds |
| 06/25/2009 | US20090163594 Triple Assay System for Identifying Substrate Selectivity of Gamma Secretase Inhibitors |
| 06/25/2009 | US20090163496 Antibacterial agents |
| 06/25/2009 | US20090163487 N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors |
| 06/25/2009 | CA2709383A1 Histone deacetylase inhibitors |
| 06/24/2009 | EP1713769B1 Amorphous tamsulosin hydrochloride |
| 06/24/2009 | CN101466665A Compositions useful as inhibitors of voltage-gated sodium channels |
| 06/24/2009 | CN101462987A Novel unsymmetrical preparation of tamsulosin hydrochloride |
| 06/24/2009 | CN101462986A Method for synthesizing (R)-5-(2-amino propyl)-2-methoxybenzenesulfonamide |
| 06/24/2009 | CN100503589C Sulphona mide derivatives as prodrugs of aspartyl protease inhibitors |
| 06/24/2009 | CN100503561C Oxo fluoroalkyl sulfamide compound and its preparing method and use |
| 06/24/2009 | CN100503560C Substituted cyclohexane derivatives |
| 06/23/2009 | US7550629 4-chloro-N-[(1S)-3,3,3-trifluoro-1-(hydroxymethyl)-2-(trifluoromethyl)propyl]benzenesulfonamide; 4-cyano-N-(3,3,3-trifluoro-1-hydroxymethyl-2-trifluoromethyl-propyl)-benzenesulfonamide; Alzheimer's Disease, amyloid angiopathy, systemic amyloidosis, mild cognitive impairment and Down's syndrome |
| 06/23/2009 | US7550489 N-[3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-(5-trifluoromethyl-2-pyridyloxy)-2-methylpropanamide and phentermine, metformin, or bupropion; obesity; antipsychotic agents; synergistic; cannabinoid receptor antagonists |
| 06/23/2009 | US7550461 Benzofuran and benzothiophene compounds useful in treating cytokine mediated diseases |
| 06/18/2009 | US20090156614 Selective androgen receptor modulators, analogs and derivatives thereof and uses thereof |
| 06/18/2009 | US20090155203 Thrombopoietin mimetics |
| 06/17/2009 | EP2069291A1 Hdac inhibitors |
| 06/17/2009 | EP2068857A2 Soluble epoxide hydrolase inhibitors |
| 06/17/2009 | CN101460454A Lysine related derivatives as HIV aspartyl protease inhibitors |
| 06/17/2009 | CN101460453A Novel sulfonamide compounds |
| 06/17/2009 | CN101456832A Method for preparing bis(trifluoromethanesulfonyl)imide metal salt |
| 06/16/2009 | US7547800 Process for trans-4-amino-1-cyclohexanecarboxylic acid derivatives |
| 06/16/2009 | US7547731 Antiinflammatory agents; antiallergens; respiratory system disorders |
| 06/16/2009 | US7547716 Sulfonamide derivatives |
| 06/11/2009 | WO2009073427A1 Fluorinated alkanesulfonic acid esters and amides and processes for making and using the same |
| 06/11/2009 | WO2009071947A2 Potassium ion channel modulators and uses thereof |
| 06/11/2009 | US20090149510 Compositions and methods for modulating a kinase cascade |
| 06/11/2009 | US20090149445 Tricyclic steroid hormone nuclear receptor modulators |
| 06/11/2009 | US20090149415 Compounds for modulating the glycolysis enzyme complex and/or the transaminase complex |
| 06/10/2009 | EP1838773B1 Fluorochemical diesters as repellent polymer melt additives |
| 06/09/2009 | US7544835 Carboxylic acid derivative and salt thereof |
| 06/09/2009 | US7544717 2-amino- and 2-thio- substituted 1,3-diaminopropanes |
| 06/09/2009 | US7544711 Cyclooxygenase inhibitors; musculoskeletal and cardiovascular disorders; antiinflammatory agents |
| 06/09/2009 | US7544699 Aryl and heteroaryl compounds, compositions, and methods of use |
| 06/09/2009 | US7544690 MCH receptor antagonists |
| 06/09/2009 | US7544637 2-cyano-3(halo)alkoxy-benzenesulfonamide compounds for combating animal pests |
| 06/09/2009 | CA2251331C Calcilytic compounds |
| 06/04/2009 | WO2009040289A3 Biaryl sulfonamide derivatives |
| 06/04/2009 | WO2009038879A3 Stem cell differentiating agents and uses therefor |
| 06/04/2009 | US20090143621 Method of Forming Alkoxylated Fluoroalcohols |
| 06/04/2009 | US20090143592 Glucagon Antagonists/Inverse Agonists |
| 06/04/2009 | US20090143386 Human adam-10 inhibitors |
| 06/03/2009 | EP2064177A2 Protease inhibitors |
| 06/03/2009 | EP1648861B1 Process for the preparation of cpla 2 inhibitors |
| 06/03/2009 | CN101448784A (2R)-2-[(4-sulfonyl)aminophenyl]propanamides and pharmaceutical compositions containing them |
| 06/03/2009 | CN100494203C Functionalized ionic liquids, and methods of use thereof |
| 06/03/2009 | CN100494172C Method of preparing 2-chloro-3-nitro-5-carboxyl benzenesulfonamide |
| 06/02/2009 | US7541492 reacting a compound containing [CF3SO2NCF3] anion and silver cation with 1-ethyl-3-methylimidazolium iodide to form a compound containing 1-ethyl-3-methylimidazolium cation and N< (SO2CF3) (CF3) anion; electrolyte for lithium batteries; ionic liquids; salt formation |
| 06/02/2009 | US7541383 Use of carboxylic acid derivatives which modulate the function and/or expression of proteins involved in atopic diseases, inflammatory conditions and cancer; treatment of asthma, allergic diseases and immunologic diseases |
| 06/02/2009 | US7541381 Sulfur compounds such as 3-((4-chloroanilino)sulfonyl)thio-phene-2-carboxylic acid, used as enzymes inhibitors for prophylaxis of antibiotic resistant bacterial infections |
| 06/02/2009 | CA2464917C Racemic tamsulosin free base and methods of making the same |
| 06/02/2009 | CA2116421C Inhibitors of hydroxyphenylpyruvate dioxygenase and an assay for identification of inhibitors |
| 05/28/2009 | WO2009067597A1 4- (or 5-) substituted catechol derivatives |
| 05/28/2009 | US20090137844 Crystallization process |
| 05/28/2009 | US20090137773 Production Processes and Systems, Compositions, Surfactants, Monomer Units, Metal Complexes, Phosphate Esters, Glycols, Aqueous Film Forming Foams, and Foam Stabilizers |
| 05/28/2009 | US20090137681 Sirtuin Inhibiting Compounds |
| 05/28/2009 | US20090137585 N-acylsulfonamide apoptosis promoters |
| 05/27/2009 | EP2062878A1 Hydrazine amide derivative |
| 05/27/2009 | EP1519915B1 Tricyclic steroid hormone nuclear receptor modulators |
| 05/27/2009 | CN101440051A Preparation of anion fluoride-containing sarcosinate surfactant |
| 05/26/2009 | US7538246 Trifluoroacetate blocking of alanine amino group, friedel crafts reaction with methoxybenzene, reduction of carbonyl group, chlorosulphonation and deprotection; claimed tamsulosin intermediates; simplification |
| 05/26/2009 | US7538241 Such as methyl 3,5-dihydroxy-2-phenylphenylacetate; antitumor activity; leukemia, multiple myeloma, lymphoma; heat shock protein 90 (Hsp90) suppression |
| 05/26/2009 | US7538127 phenethanolamine derivatives like 1-(4-amino-3,5-dichlorophenyl)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]ethanol; respiratory diseases like bronchial asthma; selective stimulant of beta 2-adrenoreceptors; reductive amination; alkylation |
| 05/26/2009 | CA2459432C Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders |
| 05/26/2009 | CA2344058C Diaminopropionic acid derivatives |